Copegus

Active Ingredient(s): Ribavirin
FDA Approved: * December 3, 2002
Pharm Company: * ROCHE
Category: Antiviral

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Copegus Overview

The most successful ribavirin derivative to date is the 3-carboxamidine derivative of the parent 3-carboxamide, first reported in 1973 by J. T. Witkowski et al.,[43] and now called taribavirin (former names "viramidine" and "ribamidine"). This drug shows a similar spectrum of antiviral activity to ribavirin, which is not surprising as it is now known to be a pro-drug for ribavirin. Taribavirin, however, has useful properties of less erythrocyte-trapping and better liver-target...

Read more Copegus Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ribavirin

Recent Copegus Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Copegus: (1 result)

Sorted by National Drug Code

• 0004-0086 Copegus 200 mg Oral Tablet by Genentech, Inc.

Other drugs which contain Ribavirin or a similar ingredient: (10 results)

• REBETOL Ribavirin
• RIBASPHERE Ribavirin
• RIBAVARIN Ribavirin2 discussions
• RIBAVIRIN 2 discussions
• VIRAZOLE Ribavirin
• INTERFERON ALFA-2B + RIBAVIRIN
• PEGINTERFERON Peginterferon Alfa-2a + Ribavirin1 discussion
• PEGINTERFERON ALFA-2A + RIBAVIRIN 1 discussion
• PEGINTRON/REBETOL COMBO PACK Peginterferon Alfa-2b + Ribavirin
• REBETRON Interferon Alfa-2b + Ribavirin